← Evidence map

ArticleFrontiers in oncology2022

RUNX2 facilitates aggressiveness and chemoresistance of triple negative breast cancer cells

Wentao Si et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

13 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36483054